Inflammatory bowel diseases: where we are and where we should go

被引：6
|
作者：
Tonutti, Elio [2 ]
Agostinis, Paolo [3 ]
Bizzaro, Nicola [1 ]
机构：
[1] Osped San Antonio, Lab Patol Clin, I-33028 Tolmezzo, Italy
[2] Azienda Osped Univ S Maria della Misericordia, Immunopatol & Allergol Clin, Udine, Italy
[3] Osped San Antonio, Unita Med Interna, Serv Gastroenterol, I-33028 Tolmezzo, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2014年 / 52卷 / 04期
关键词：
ANTIBODIES;
D O I：
10.1515/cclm-2014-0146
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：463 / 465
页数：3
相关论文
共 50 条
  • [41] Personalized medicine and healthcare: where are we now, where should we go?
    Laszlo, Gulacsi
    Szabolcs, Bekassy
    Nora, Bittner
    Judit, Feith Helga
    Andrea, Ficzere
    Lajos, Horvath
    Zsolt, Horvath
    Ico, Toth
    Zsombor, Zrubka
    Erika, Toth
    Gabor, Kovacs L.
    ORVOSI HETILAP, 2023, 164 (06) : 202 - 209
  • [42] CHEST PAIN OF ESOPHAGEAL ORIGIN - WHERE ARE WE, AND WHERE SHOULD WE GO
    BENJAMIN, SB
    CASTELL, DO
    ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (04) : 772 - 776
  • [43] Pheochromocytoma - where are we? Where should we go? A medical and scientific odyssey
    Neumann, HPH
    Opocher, G
    Januszewicz, A
    Eng, C
    FAMILIAL CANCER, 2005, 4 (01) : 1 - 1
  • [44] Pheochromocytoma – where are we? Where should we go? A medical and scientific odysseyReview
    Hartmut P. H. Neumann
    Giuseppe Opocher
    Andrzej Januszewicz
    Charis Eng
    Familial Cancer, 2005, 4 : 1 - 1
  • [45] Catfish Sampling Techniques: Where We Are Now and Where We Should Go
    Bodine, Kristopher A.
    Shoup, Daniel E.
    Olive, Jason
    Ford, Zachary L.
    Krogman, Rebecca
    Stubbs, Tyler J.
    FISHERIES, 2013, 38 (12) : 529 - 546
  • [46] Dissemination research in cancer control: where are we and where should we go?
    Deborah J. Bowen
    Glorian Sorensen
    Bryan J. Weiner
    Marci Campbell
    Karen Emmons
    Cathy Melvin
    Cancer Causes & Control, 2009, 20 : 473 - 485
  • [47] STEM CELL GENE THERAPY FOR PRIMARY IMMUNODEFICIENCY DISEASES: WHERE ARE WE TODAY AND WHERE SHOULD WE GO?
    Otsu, Makoto
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 216 - 217
  • [48] Digital human resource development: where are we? Where should we go and how do we go there?
    Thite, Mohan
    HUMAN RESOURCE DEVELOPMENT INTERNATIONAL, 2022, 25 (01) : 87 - 103
  • [49] Where we should be and where we are
    Corral De la Calle, M. A.
    RADIOLOGIA, 2010, 52 (03): : 193 - 195
  • [50] Child preference in custody decisions: Where we have been, where we are now, where we should go
    Nemechek, K
    IOWA LAW REVIEW, 1998, 83 (02) : 437 - 469
12345